Unraveling the role of gut microbiome in predicting adverse events in neoadjuvant therapy for rectal cancer

Jingxin Ma, Shengbo Sun, Xin Cheng, Cong Meng, Hanzheng Zhao, Wentao Fu, Yan Gao, Liyan Ma, Zhengyang Yang, Hongwei Yao, Jianrong Su · 2024

Read Unraveling the role of gut microbiome in predicting adverse events in neoadjuvant therapy for rectal cancer by Jingxin Ma, Shengbo Sun, Xin Cheng, Cong Meng, Hanzheng Zhao, Wentao Fu, Yan Gao, Liyan Ma, Zhengyang Yang, Hongwei Yao, Jianrong Su (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11622589.txt.

Description

Jingxin Ma and co-authors study in 2024 whether gut microbes can foretell which rectal cancer patients will suffer side effects from treatment given before surgery. The treatment mixes chemotherapy, radiation, and immune therapy, and it can trigger harms that cut response rates. The role of gut microbes and their products in those harms was unclear.

The team took stool samples before treatment from 21 patients who later had adverse events and 11 who did not. Deep gene sequencing listed the microbes, and a broad chemical scan listed their products. Some bacterial species were richer in the group that stayed well, and others in the group that fell ill. A stool test before treatment could warn teams to adjust doses or add support.

Catalog record

CREATORJingxin Ma, Shengbo Sun, Xin Cheng, Cong Meng, Hanzheng Zhao, Wentao Fu, Yan Gao, Liyan Ma, Zhengyang Yang, Hongwei Yao, Jianrong Su
YEAR2024
COLLECTIONPAPERS
FORMATTXT
FILE SIZE44 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11622589

Browse the full library · About the Tower of Babel